Understanding how nutrition affects growth in premature infants
Official title: Growing Little PEAPODS Study: Association Between Prematurity and Body Composition, Nutrition Practices, and Neurodevelopmental Outcomes
Run by University of Wisconsin, Madison · NCT06226051 · Data updated 2026-11-12
This study looks at how the food that premature babies eat in the NICU affects their growth and development over three years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Weeks to 32 Weeks |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 1 site (Madison, Wisconsin) |
| Status | Recruiting |
| Started | September 4, 2024 |
| Main results expected | January 2028 |
| Study ends | January 2028 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT06226051 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are neonates born at Meriter Hospital between 22 and 32 weeks of gestational age.
✕Probably not a fit
Patients with known genetic conditions affecting neurodevelopment or those requiring transfer to another hospital before 36 weeks post-menstrual age may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the impact of nutrition on the growth and development of premature infants in the Neonatal Intensive Care Unit (NICU). Participants will have their body growth measurements taken using the PEAPOD device, and nutritional information will be collected to assess its influence on weight gain and fat-free mass. The study will follow these infants for neurodevelopmental outcomes over a period of 36 months.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional strategies that enhance growth and development in premature infants.
How similar studies have gone: While similar studies have explored nutrition in premature infants, this specific approach using the PEAPOD device for body composition measurement is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Neonate Inclusion Criteria: * Born inpatient at Meriter Hospital, Inc. at or above 22 gestational weeks. Upper limit is 32 weeks 6 days GA (possible gestational age range from 22w0d-32w6d) Neonate Exclusion Criteria: * Known genetic condition that impacts neurodevelopmental outcomes or brain structure development * Multiple major congenital anomalies * Per the investigator's opinion, the subject will likely require transfer to American Family Children's Hospital (AFCH) before 36 weeks PMA * Any neonate who enrolls in the study and then unexpectedly requires transfer to AFCH before 36 weeks PMA will be excluded from the study if they are unable to obtain at least one body composition measurement before transfer. Body composition data points can only be collected at Meriter Hospital due to the location of PEAPOD Birthing Parent Inclusion Criteria: * Birthing parent must speak English or Spanish due to consent documents * Able to understand and willing to sign a written informed consent document * Primary caregiver of a neonate who is eligible to participate in the study * Agrees to enroll neonate into the study * Willing to comply with all study procedures and be available for the duration of the study * Age 15 or older Birthing Parent Exclusion Criteria: * Subject is unable to provide informed consent, including subjects in foster care and subjects within state custody * Does not plan to maintain custody of the child after birth, such as in instances of adoption or surrogacy
Where it's running
-
Meriter Hospital, Inc.
Madison, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Whitley Hulse, MD — University of Wisconsin, Madison
- Study coordinator: Whitley Hulse, MD
- Email: whulse@wisc.edu
- Phone: 608-620-4924
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Wireless MicroPremVitals Button Sensor for the NICU
This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.
-
Breast milk and sugar solutions to ease heel-prick pain in premature babies
This study tests whether oral breastfeeding or sugary solutions help relieve pain in premature newborns during a heel-prick blood draw.
-
Gentle Touch and Sensory Changes to Ease Heel Pricks in Preterm Babies
This study tests whether gentle human touch or a quiet, reduced-stimulation environment can reduce pain and improve comfort during heel blood collection for premature infants.
-
Automated oxygen control for preterm babies on non-invasive support
This trial tests whether closed-loop automated oxygen control helps preterm babies on non-invasive ventilation reach target oxygen levels more often and spend less time on supplemental oxygen compared with manual control.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.